SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001561743-17-000025
Filing Date
2017-06-08
Accepted
2017-06-08 17:02:39
Documents
4
Effectiveness Date
2017-06-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2017proxynotice.htm DEFA14A 28010
2 a2017notice1.jpg GRAPHIC 136736
3 a2017notice2.jpg GRAPHIC 230227
4 a2017notice3.jpg GRAPHIC 46656
  Complete submission text file 0001561743-17-000025.txt   582777
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36225 | Film No.: 17900808
SIC: 2834 Pharmaceutical Preparations